BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23169601)

  • 1. Muscle phenotype in patients with myotonic dystrophy type 1.
    Andersen G; Ørngreen MC; Preisler N; Colding-Jørgensen E; Clausen T; Duno M; Jeppesen TD; Vissing J
    Muscle Nerve; 2013 Mar; 47(3):409-15. PubMed ID: 23169601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).
    Moxley RT; Logigian EL; Martens WB; Annis CL; Pandya S; Moxley RT; Barbieri CA; Dilek N; Wiegner AW; Thornton CA
    Muscle Nerve; 2007 Sep; 36(3):320-8. PubMed ID: 17587223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital myotonic dystrophy: variability in muscle involvement and histopathological process.
    Kuo HC; Huang CC; Chu CC; Wai YY; Hsiao KM; Chu NS
    Acta Neurol Taiwan; 2006 Mar; 15(1):13-20. PubMed ID: 16599279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of CTG repeat expansion on quantitative muscle histopathology in myotonic dystrophy].
    Utsugisawa K; Yamagata M; Nagane Y; Tohgi H
    Nihon Rinsho; 1997 Dec; 55(12):3214-8. PubMed ID: 9436439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of myotonic dystrophy showing proximal dominant muscle involvement but not myotonia].
    Mihori A; Miyauchi H; Kaneda K; Nakayama M; Ono S; Shimizu N
    Rinsho Shinkeigaku; 1999 Apr; 39(4):461-4. PubMed ID: 10391974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotonic dystrophy type 2 with focal asymmetric muscle weakness and no electrical myotonia.
    Milone M; Batish SD; Daube JR
    Muscle Nerve; 2009 Mar; 39(3):383-5. PubMed ID: 19208413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
    Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
    Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristic MRI Findings of upper Limb Muscle Involvement in Myotonic Dystrophy Type 1.
    Sugie K; Sugie M; Taoka T; Tonomura Y; Kumazawa A; Izumi T; Kichikawa K; Ueno S
    PLoS One; 2015; 10(4):e0125051. PubMed ID: 25919300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1.
    Thornell LE; Lindstöm M; Renault V; Klein A; Mouly V; Ansved T; Butler-Browne G; Furling D
    Neuropathol Appl Neurobiol; 2009 Dec; 35(6):603-13. PubMed ID: 19207265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between distribution of muscle weakness, electrophysiological findings and CTG expansion in myotonic dystrophy.
    Khoshbakht R; Soltanzadeh A; Zamani B; Abdi S; Gharagozli K; Kahrizi K; Khoshbakht R; Nafissi S
    J Clin Neurosci; 2014 Jul; 21(7):1123-6. PubMed ID: 24417793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic dystrophy with no trinucleotide repeat expansion.
    Thornton CA; Griggs RC; Moxley RT
    Ann Neurol; 1994 Mar; 35(3):269-72. PubMed ID: 8122879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonia congenita and myotonic dystrophy in the same family: coexistence of a CLCN1 mutation and expansion in the CNBP (ZNF9) gene.
    Sun C; Van Ghelue M; Tranebjærg L; Thyssen F; Nilssen Ø; Torbergsen T
    Clin Genet; 2011 Dec; 80(6):574-80. PubMed ID: 21204798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal myotonic myopathy. Analysis of 3 Swedish cases.
    Schuitevoerder K; Ansved T; Solders G; Borg K
    Acta Neurol Scand; 1997 Oct; 96(4):266-70. PubMed ID: 9325482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, electrophysiologic and pathologic findings in 10 patients with myotonic dystrophy 2.
    Dabby R; Sadeh M; Herman O; Leibou L; Kremer E; Mordechai S; Watemberg N; Frand J
    Isr Med Assoc J; 2011 Dec; 13(12):745-7. PubMed ID: 22332444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Winged scapula in patients with myotonic dystrophy type 1.
    Hamano T; Mutoh T; Hirayama M; Uematsu H; Higuchi I; Koga H; Umehara F; Komai K; Kuriyama M
    Neuromuscul Disord; 2012 Aug; 22(8):755-8. PubMed ID: 22683376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTG-repeat length in distal and proximal leg muscles of symptomatic and non-symptomatic patients with myotonic dystrophy: relation to muscle strength and degree of histopathological abnormalities.
    Hedberg B; Anvret M; Ansved T
    Eur J Neurol; 1999 May; 6(3):341-6. PubMed ID: 10210916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility of muscles to myotonia and force impairment in a mouse model of myotonic dystrophy.
    Moyer M; Berger DS; Ladd AN; Van Lunteren E
    Muscle Nerve; 2011 Jun; 43(6):818-27. PubMed ID: 21404300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Muscular disability and organ impairments in myotonic dystrophy type 1].
    Pruna L; Machado F; Louis L; Vassé G; Kaminsky P
    Rev Neurol (Paris); 2011 Jan; 167(1):23-8. PubMed ID: 20934732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin-proteasome pathway.
    Vignaud A; Ferry A; Huguet A; Baraibar M; Trollet C; Hyzewicz J; Butler-Browne G; Puymirat J; Gourdon G; Furling D
    Neuromuscul Disord; 2010 May; 20(5):319-25. PubMed ID: 20346670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.